Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2023-12-04 00:00:00 ET · period of report 2023-11-19 · accession 0001628280-23-040675 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-04 | 2023-12-01 | BLFS | Mathew Aby J. | EVP, CSO | S - Sale | $12.37 | -591 | 276.0K | -0.2% | -$7,311 | |
| 2023-12-04 | 2023-11-19 | BLFS | Mathew Aby J. | EVP, CSO | A - Grant | — | +826 | 276.6K | +0.3% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-01 | S | D | 591 | $12.37 | 275,961 | D | — | — | |
| 2 | Common | Common Stock | 2023-11-19 | A | A | 826 | — | 276,552 | D | — | — | (F1) The shares of restricted stock reported herein were issued to the reporting person in lieu of a portion of cash salary at the last closing price as of the date of grant. |